返回首頁 > 醫師介紹
姓名: 邢福柳(Eng Hock-Liew)
學歷: 台灣大學醫學系, M.D., 1981
經歷:
現職: 顧問醫師/部定教授
教職: 長庚大學醫學系兼任副教授
信箱:
研究計畫:

邢福柳醫師3年內研究計畫:

1. 2014.08~2015.07 科技部 #103-2320-B-182A-007-

    干擾素和類鐸受體對巨嗜細胞活化及行結核分枝桿菌吞噬作用時之交互調控

2. 2013.08~2014.10 科技部 #102-2320-B-182A-003

    類鐸受體多型性對結核分枝桿菌感染單核球之影響及調控

3. 2014.08~2016.07 科技部 #103-2320-B-182A-007

    干擾素和類鐸受體對巨嗜細胞活化及行結核分枝桿菌吞噬作用時之交互調控

4. 2012.03~2015.02 長庚醫院 #CMRPG8A1161

     肝內膽道癌之全基因及臨床病理特徵之相關性研究

5. 2013.01~2015.12 疾管局102~104年度病毒性感染症合約實驗室委託檢驗計畫

 

重要著作:

論文著作338
近期代表著作:

  1. Eng HL, Hsu YY, Lin TM. Differences in TLR7/8 activation between monocytes and macrophages. Biochem Biophys Res Commun. 2018 Feb 26;497(1):319-325.
  2. Lai YF, Lin TM, Wang CH, Su PY, Wu JT, Lin MC, Eng HL. Functional polymorphisms of the TLR7 and TLR8 genes contribute to mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2016 May;98:125-31.  (corresponding author)
  3. Huang WT, Weng SW, Wei YC, You HL, Wang JT, Eng HL. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol 2014; 7: 6841-51. (corresponding author)
  4. Lin KJ, Lin TM, Wang CH, Liu HC, Lin YL,  Eng HL. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus–related human hepatocellular carcinoma.Human Pathol 2013; 44:534–41  (corresponding author)
  5. You HL, Lin TM, Wang JC, Li CC, Chao TL, Liao WT, Eng HL. Mannose-binding lectin gene polymorphisms and mycobacterial lymphadenitis in pediatric patients. Ped Infect Dis J 09/2013; 32(9): 1005-9 (corresponding author)
  6. Li CC, Wang L, Eng HL, You HL, Chang LS, Tang KS, Ling YJ, Kuo HC, Lee IK, Liu JW, Huang EY, Yang KD. Correlation of pandemic (H1N1) 2009 viral load with disease severity and  prolonged viral shedding in children.  Emerging Infectious diseases 2010; 16: 1265-1272. (Co-first author)
  
版權所有 © 網站內容為高雄長庚紀念醫院解剖病理部 所有   網站最佳瀏覽解析度為 1024X768  Designed by D-Spring
高雄市鳥松區大埤路 123 號3樓 TEL:(07)731-7123轉2100 FAX:(07)733-3198
網頁負責人:李瀅代 最新更新日期:2024年01月05日